Preta Martina Cavazza - Net Worth and Insider Trading

Preta Martina Cavazza Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Preta Martina Cavazza owns 3 companies in total, including Regenerx Biopharmaceuticals Inc (RGRX) , Fennec Pharmaceuticals Inc (FENC) , and Soligenix Inc (SNGX) .

Click here to see the complete history of Preta Martina Cavazza’s form 4 insider trades.

Insider Ownership Summary of Preta Martina Cavazza

Ticker	Comapny	Transaction Date	Type of Owner
RGRX	Regenerx Biopharmaceuticals Inc	2018-03-13	10 percent owner
FENC	Fennec Pharmaceuticals Inc	2017-09-11	10 percent owner
SNGX	Soligenix Inc	2017-11-29	other: Former 10% Owner

Preta Martina Cavazza Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Preta Martina Cavazza Ownership Network

Ownership Network List of Preta Martina Cavazza

No Data

Ownership Network Relation of Preta Martina Cavazza

Preta Martina Cavazza Owned Company Details

What does Regenerx Biopharmaceuticals Inc do?

Who are the key executives at Regenerx Biopharmaceuticals Inc?

Preta Martina Cavazza is the 10 percent owner of Regenerx Biopharmaceuticals Inc. Other key executives at Regenerx Biopharmaceuticals Inc include other: Member of 10% owner group Aptafin S P A , 10 percent owner Spa Essetifin , and 10 percent owner Francesca Cavazza .

Regenerx Biopharmaceuticals Inc (RGRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Regenerx Biopharmaceuticals Inc (RGRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regenerx Biopharmaceuticals Inc (RGRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Regenerx Biopharmaceuticals Inc (RGRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Regenerx Biopharmaceuticals Inc Insider Transactions

No Available Data

What does Fennec Pharmaceuticals Inc do?

Who are the key executives at Fennec Pharmaceuticals Inc?

Preta Martina Cavazza is the 10 percent owner of Fennec Pharmaceuticals Inc. Other key executives at Fennec Pharmaceuticals Inc include director & Chief Executive Officer Rosty Raykov , Chief Financial Officer Robert Andrade , and Chief Commercial Officer Shubh Goel .

Fennec Pharmaceuticals Inc (FENC) Insider Trades Summary

Over the past 18 months, Preta Martina Cavazza made no insider transaction in Fennec Pharmaceuticals Inc (FENC). Other recent insider transactions involving Fennec Pharmaceuticals Inc (FENC) include a net sale of 170,022 shares made by Rosty Raykov , a net sale of 17,180 shares made by Chris A Rallis , and a net sale of 82,950 shares made by Robert Andrade .

In summary, during the past 3 months, insiders sold 8,466 shares of Fennec Pharmaceuticals Inc (FENC) in total and bought 0 shares, with a net sale of 8,466 shares. During the past 18 months, 492,373 shares of Fennec Pharmaceuticals Inc (FENC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 492,373 shares.

Fennec Pharmaceuticals Inc (FENC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Fennec Pharmaceuticals Inc Insider Transactions

No Available Data

What does Soligenix Inc do?

Who are the key executives at Soligenix Inc?

Preta Martina Cavazza is the other: Former 10% Owner of Soligenix Inc. Other key executives at Soligenix Inc include CMO Richard Straube , director & Chairman & CEO and President Christopher Schaber , and Chief Financial Officer Jonathan L. Guarino .

Soligenix Inc (SNGX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Soligenix Inc (SNGX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Soligenix Inc (SNGX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Soligenix Inc (SNGX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Soligenix Inc Insider Transactions

No Available Data

Preta Martina Cavazza Mailing Address

Above is the net worth, insider trading, and ownership report for Preta Martina Cavazza. You might contact Preta Martina Cavazza via mailing address: Via Sudafrica 20, Rome L6 00144.

Discussions on Preta Martina Cavazza

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.